Profile
Michael L.
Salgaller served as President & Chief Operating Officer at Biologics Consulting Group, Inc. He was a Senior Associate at Toucan Capital Corp.
from 2003 to 2008.
He also worked as Principal at National Institutes of Health and as Chief Operating Officer at Calibrant Biosystems, Inc. Salgaller holds a doctorate from The Ohio State University, a graduate degree from the University of Dayton, and an undergraduate degree from Washington & Jefferson College.
Former positions of Michael L. Salgaller
| Companies | Position | End |
|---|---|---|
Toucan Capital Corp.
 Toucan Capital Corp. Investment ManagersFinance Toucan Capital Corp (Toucan Capital) is a private equity firm founded in 1997 by Linda F. Powers and Robert F. Hemphill. The firm is headquartered in Bethesda, Maryland. | Private Equity Analyst | 01/01/2008 |
Calibrant Biosystems, Inc.
 Calibrant Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Calibrant Biosystems, Inc. operated as a biotechnology company that engaged in the discovery and development of protein drug targets and markers for the treatment and diagnosis of diseases. It offered therapeutics, protein drug targets, disease pathways, and biomarkers from micro dissected human tissue specimens. The company was founded by Cheng S. Lee and Don L. DeVoe in 2000 and is headquartered in Bethesda, MD. | Chief Operating Officer | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Biologics Consulting Group, Inc.
 Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | President | 11/10/2011 |
Training of Michael L. Salgaller
| The Ohio State University | Doctorate Degree |
| University of Dayton | Graduate Degree |
| Washington & Jefferson College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Commercial Services |
Toucan Capital Corp.
Toucan Capital Corp. Investment ManagersFinance Toucan Capital Corp (Toucan Capital) is a private equity firm founded in 1997 by Linda F. Powers and Robert F. Hemphill. The firm is headquartered in Bethesda, Maryland. | Finance |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Calibrant Biosystems, Inc.
Calibrant Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Calibrant Biosystems, Inc. operated as a biotechnology company that engaged in the discovery and development of protein drug targets and markers for the treatment and diagnosis of diseases. It offered therapeutics, protein drug targets, disease pathways, and biomarkers from micro dissected human tissue specimens. The company was founded by Cheng S. Lee and Don L. DeVoe in 2000 and is headquartered in Bethesda, MD. | Health Technology |
- Stock Market
- Insiders
- Michael L. Salgaller
